Trends in Spending and Claims for P2Y12 Inhibitors by Medicare and Medicaid From 2015 to 2020

Lignende værker

• Medicare Part B and Part D drug eligibility for center for Medicare and Medicaid Services price negotiation under the Inflation Reduction Act: estimates using 2016–2019 data
  af: Omar Qureshi, et al.
  Udgivet: (2024-12-01)
• Association between physician adoption of a new oral anti-diabetic medication and Medicare and Medicaid drug spending
  af: Ilinca D. Metes, et al.
  Udgivet: (2019-10-01)
• Trends in Anticoagulation Prescription Spending Among Medicare Part D and Medicaid Beneficiaries Between 2014 and 2019
  af: Angela Duvalyan, et al.
  Udgivet: (2021-12-01)
• The impact of Medicare part D on income-related inequality in pharmaceutical expenditure
  af: Natalie Carvalho, et al.
  Udgivet: (2019-04-01)
• Use of preventive service and potentially preventable hospitalization among American adults with disability: Longitudinal analysis of Traditional Medicare and commercial insurance
  af: Elham Mahmoudi, et al.
  Udgivet: (2024-04-01)